FDA Drug Application (017122) for DARVOCET-N 50 by XANODYNE PHARM

Back to FDA Applications sponsored by XANODYNE PHARM

Application Number017122
Product Number001
FormTABLET;ORAL
Dosage325MG;50MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDARVOCET-N 50
Active IngredientACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient PROPOXYPHENE NAPSYLATE7


Back to FDA Applications sponsored by XANODYNE PHARM